ʻO Ursofalk no nā maʻi ate a me ka gallbladder

Anter

• No ke aha ia
• Pehea e lawe ai
• Nā hopena ʻē aʻe

ʻO Ursofalk kahi lāʻau i hōʻike ʻia no ka hoʻopau ʻia ʻana o nā pōhaku i ka gallbladder a i ʻole nā ​​maʻi ʻē aʻe o ka gallbladder, ka mālama ʻana i ka cirrhosis biliary mua, ka mālama ʻana i ka digestion maikaʻi ʻole a me nā loli qualitative i ka bile, a me nā mea ʻē aʻe.

Aia kēia lāʻau i loko o kāna ʻano ursodeoxycholic acid, kahi mea physiologically i loaʻa i ka bile kanaka, ʻoiai i ka nui o ka nui. Hoʻopili kēia waiʻakika i ka synthesist o kolesterol i ke akepaʻa a hoʻoulu i ka synthes o nā bile acid, e hoʻihoʻi i ke kaulike ma waena o lākou. Hoʻohui ʻia, hāʻawi pū kekahi ia i ka solubilization o ka cholesterol e ka bile, e pale ana i ke kūkulu ʻia ʻana o nā gallstones a i ʻole makemake i ko lākou luhi.

No ke aha ia

ʻO ka Ursodeoxycholic acid kahi lāʻau i hōʻike ʻia no nā maʻi o ke ake, ka pehu a me nā aʻa aʻa, i nā ʻano aʻe:

• ʻO nā Gallstones i hana ʻia e ka cholesterol i kekahi mau maʻi;
• Nā ʻōuli o ka cirrhosis biliary mua;
• ʻO ka pōhaku koena i ke kahawai o ka gallbladder a i ʻole nā ​​pōhaku hou i hana ʻia ma hope o ke kahakaha ʻana o nā kaola o ka bile;
• Nā ʻōuli o ka digestion maikaʻi ʻole, e like me ka ʻeha o ka ʻōpū, ʻehaʻeha ka puʻuwai a me ka piha, i kumu ʻia e nā maʻi o ka pākī;
• Nā loli i ka hana o ka cystic conduit a i ʻole gallbladder a me nā syndrome e pili ana;
• Nā pae kiʻekiʻe o ke kolesterol a i ʻole triglycerides;
• Kākoʻo i ka hoʻomaʻamaʻa i ka hoʻopau ʻana o nā gallstones e nā nalu haʻalulu, i hoʻokumu ʻia e ka cholesterol i nā mea maʻi me cholelithiasis;
• Hoʻololi kūpono a me nā nui i ka bile.

ʻIke pehea e ʻike ai i nā ʻōuli o nā pōhaku.

Pehea e lawe ai

Pono e hoʻoholo ʻia nā kauka Ursofalk e ke kauka.

No ka hoʻohana lōʻihi, e pale i ke kūkulu ʻana o nā pōhaku, ʻo ka mahele maʻamau he 5 a 10 mg / kg / lā, ke anawaena maʻamau, ma ka hapanui o nā hihia, ma waena o 300 a 600 mg, i kēlā me kēia lā, no 4 a 6 mau mahina. a hiki i 12 mau mahina a ʻoi paha. ʻAʻole pono e ʻoi aku ka maikaʻi ma mua o ʻelua makahiki.

I nā syndrome dyspeptic a me ka mālama mālama, ʻo nā kaha o 300 mg i kēlā me kēia lā e lawa lawa, ʻāpana ʻia i 2 a i 3 mau hoʻokele, akā hiki ke hoʻololi ʻia kēia mau kaha e ke kauka.

I nā mea maʻi e mālama ana i ka lāʻau no ka hoʻopau ʻana o ka pōhaku, he mea nui e nānā i ka maikaʻi o ka waikawa ursodeoxycholic, ma o nā hōʻike cholecystographic, i kēlā me kēia 6 mahina.

I ka hoʻopili hoʻopili o ka shockwave hoʻopau o nā gallstones, ʻo ka mālama mua ʻana me ka ursodeoxycholic acid e hoʻonui ai i nā hopena o ka lāʻau. Pono e hoʻoponopono i nā kaona o ka ursodeoxycholic acid e ke kauka, me ka awelika o 600 mg i kēlā me kēia lā.

I ka cirrhosis biliary mua, hiki ke hoʻololi i nā lāʻau mai 10 a 16 mg / kg / lā, e like me nā pae o ka maʻi. Paipai ʻia e nānā i nā mea maʻi ma o nā hoʻokolohua hana ate a me ke ana bilirubin.

Pono e mālama ʻia ka mahele lāʻau i kēlā me kēia lā i 2 a i ʻole 3 mau manawa, ke kaukaʻi ʻia i ka hōʻike i hoʻohana ʻia, ma hope o ka ʻai.

Nā hopena ʻē aʻe

ʻO ka hopena ʻaoʻao maʻamau e hiki ke hana ʻia i ka wā o ka mālama ʻana me Ursofalk ua hoʻololi ʻia ka noho o ka noho, kahi hiki ke lilo i pasty, a i ʻole ka diarrhea.

ʻO wai ka mea pono ʻole e hoʻohana

ʻAʻole pono e hoʻohana ʻia ʻo Ursofalk i nā hihia o ka maʻi āpau i ka ursodeoxycholic acid a i ʻole kekahi o nā ʻāpana o ka formulate, ka poʻe me ka ulcer peptic ulcer ʻeleu, maʻi maʻi ʻōpala a me nā kūlana ʻē aʻe o ka ʻōpū liʻiliʻi, kolona a me ke ake, i hiki ke hoʻopilikia i ka enterohepatic nā paʻakai pālahalaha, nā colic biliary pinepine, ka huʻi nui o ka gallbladder a i ʻole ka biliary tract, biliary tract tract, hoʻoliʻiliʻi gallbladder contractility a i ʻole radiopaque calcified gallstones.

Eia hou, ʻaʻole pono e hoʻohana ʻia kēia lāʻau e nā wahine hāpai me ka ʻole o ka ʻōlelo aʻoaʻo.